Dr.med. ID: 55805

Angela Schulz

graph of relations

Publications

  1. 2013
  2. Quantitative t2 measurements in juvenile and late infantile neuronal ceroid lipofuscinosis.

    Bravo, A. P., Forkert, N. D., Schulz, A., Löbel, U., Fiehler, J., Ding, X., Sedlacik, J., Rosenkranz, M. & Goebell, E., 2013, In: CLIN NEURORADIOL. 23, 3, p. 189-196 8 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2012
  4. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene

    Kousi, M., Anttila, V., Schulz, A., Calafato, S., Jakkula, E., Riesch, E., Myllykangas, L., Kalimo, H., Topçu, M., Gökben, S., Alehan, F., Lemke, J. R., Alber, M., Palotie, A., Kopra, O. & Lehesjoki, A-E., 01.06.2012, In: J MED GENET. 49, 6, p. 391-9 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Neuronale Zeroidlipofuszinosen (NCL) - Metabolische Demenzkrankheiten im Kindesalter

    Schulz, A. & Kohlschütter, A., 2012, In: MONATSSCHR KINDERH. 160, p. 734-741 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2011
  7. Analysis of Potential Biomarkers and Modifier Genes Affecting the Clinical Course of CLN3 Disease.

    Lebrun, A-H., Moll-Khasrawi, P., Pohl, S., Makrypidi, G., Storch, S., Kilian, D., Streichert, T., Otto, B., Mole, S. E., Ullrich, K., Cotman, S., Kohlschütter, A., Braulke, T. & Schulz, A., 2011, In: MOL MED. 17, 11-12, p. 1253-1261 11-12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. CLN2

    Chang, M., Cooper, J. D., Davidson, B. L., van Diggelen, O., Elleder, M., Goebel, H. H., Golabek, A. A., Kida, E., Kohlschütter, A., Lobel, P., Mole, S. E., Schulz, A., Sleat, D. E., Warburton, M. & Wisniewski, K. E., 2011, The Neuronal Ceroid Lipofuscinoses (Batten Disease). Oxford University Press, 30 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  9. 2009
  10. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship.

    Lebrun, A-H., Storch, S., Rüschendorf, F., Schmiedt, M-L., Kyttälä, A., Mole, S. E., Kitzmüller, C., Saar, K., Mewasingh, L. D., Boda, V., Kohlschütter, A., Ullrich, K., Braulke, T. & Schulz, A., 2009, In: HUM MUTAT. 30, 5, p. 651-661 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. 2006
  12. The CLN9 protein, a regulator of dihydroceramide synthase.

    Schulz, A., Mousallem, T., Venkataramani, M., Persaud-Sawin, D-A., Zucker, A., Luberto, C., Bielawska, A., Bielawski, J., Holthuis, J. C. M., Jazwinski, S. M., Kozhaya, L., Dbaibo, G. S. & Boustany, R-M. N., 2006, In: J BIOL CHEM. 281, 5, p. 2784-2794 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. 2004
  14. Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant.

    Schulz, A., Dhar, S., Rylova, S., Dbaibo, G., Alroy, J., Hagel, C., Artacho, I., Kohlschütter, A., Lin, S. & Boustany, R-M., 2004, In: ANN NEUROL. 56, 3, p. 342-350 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2000
  16. Selective effect of tumor necrosis factor on transformed versus nontransformed cells: nonselective signal recognition but differential target cell response.

    Schulz, A. & Bauer, G., 2000, In: ANTICANCER RES. 20, 5, p. 3435-3442 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Synergistic action between tumor necrosis factor-alpha and transforming growth factor type-beta: consequences for natural antitumor mechanisms.

    Schulz, A. & Bauer, G., 2000, In: ANTICANCER RES. 20, 5, p. 3443-3448 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next